(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

FORMA DE DOSAGEM ORAL SÓLIDA CONTENDO ACETAMINOFENO E IBUPROFENO E USOS RELACIONADOS

Em AnáliseInvention PatentPCT · US2020020112

Application data

Number

112021017037

Type

Invention Patent

Filing

02/27/2020

Publication

11/09/2021

PCT

US2020020112

Progress at the INPI

Technical opinion to answer
  1. Filing02/27/20
  2. Publication11/09/21
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 10/08/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

AFT PHARMACEUTICALS LIMITED

NZ

See this company's full portfolio

Inventors

M. C. (pessoa física)

US

M. M. (pessoa física)

US

Technical data

Priority claims

US

16/287,836 · 02/27/2019

Abstract

COMPOSIÇÃO FARMACÊUTICA CONTENDO ACETAMINOFENO E IBUPROFENO. São descritas formas de dosagem oral sólidas contendo 325 mg de acetaminofeno e 97,5 mg de ibuprofeno ou 500 mg de acetaminofeno e 150 mg de ibuprofeno, em que o ibuprofeno tem um [D50] entre 1 e 9 mm.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

15.50

O pedido foi dividido no BR122024014908-7 protocolo 870240061183 em 19/07/2024 16:28.

10/08/2024

RPI 2805

Parecer de pré-exame

#6.23

07/16/2024

RPI 2793

Notificação de entrada na fase nacional - PCT

#1.3

11/09/2021

RPI 2653

Alteração de dados cadastrais

#1.1

09/08/2021

RPI 2644

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.